Recombivax HB: Clinical Trials

5 trials of Recombivax HB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Terminated 1

Follow Recombivax HB: new trials by email Literature Review of Recombivax HB trials Research Report on Recombivax HB

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
RSVt vaccine, Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine, Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine - RSV Immunization
Phase 3TerminatedSanofi Pasteur, a Sanofi Company22262024-05-132026-10-05
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)
V114, Prevnar 13™, RotaTeq™ - Pneumococcal Infections, Pneumococcal Vaccines
Phase 3CompletedMerck Sharp & Dohme LLC17202019-06-192023-07-28
A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)
Prevnar 13™, V114, RotaTeq™ - Pneumococcal Infections
Phase 3CompletedMerck Sharp & Dohme LLC9002018-10-182023-01-17
Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)
2XP HEPTAVAX™-II SC, 1XP HEPTAVAX™-II SC, 2XP HEPTAVAX™-II IM - Hepatitis B
Phase 3CompletedMerck Sharp & Dohme LLC7222011-11-292018-07-18
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
Modified Process Hepatitis B Vaccine (Experimental), Hepatitis B Vaccine (Recombinant) - Hepatitis B
Phase 3CompletedMerck Sharp & Dohme LLC17182006-10-062017-05-23

Conditions studied

Hepatitis B (2)  ·  Pneumococcal Infections (2)

Sponsors

Merck Sharp & Dohme LLC (4)  ·  Sanofi Pasteur, a Sanofi Company (1)

Countries

Puerto Rico (3)  ·  United States (3)  ·  Thailand (2)  ·  Turkey (Türkiye) (2)  ·  Mexico (1)

Results publications

PMID 21552183, PMID 29553862, PMID 36522265, PMID 36621410, PMID 37846456

NIH funding

2018 (2)